NHS Starts Blood Test Trial to Detect More Than 50 Types of Cancer
The NHS-Galleri Trial is being launched to evaluate whether a blood test may help identify cancer earlier when combined with
Read more
DISEASES
Amgen’s KRAS G12C Inhibitor Lumykras™ Receives MHRA Authorisation
Amgen’s first-in-class KRAS G12C inhibitor LumykrasTM (sotorasib) has been granted Conditional Marketing Authorisation by the Medicines and Healthcare products Regulatory
Read more
Sanofi to buy Kadmon and its First-in-class Transplant Drug in $1.9B Deal
Sanofi announced that it will purchase U.S. biotech Kadmon to enhance its transplant business for approximately $1.9 billion. Sanofi and
Read more
International Respiratory Coalition Launches to Improve Post-Pandemic Respiratory Care
The European Respiratory Society (ERS), the Global Allergy and Airways Patient Platform (GAAPP), AstraZeneca, Amgen and leading respiratory clinicians announced
Read more
First Celiac Disease Patient Dosed in Calypso IL-15 Monoclonal Antibody Trial
Calypso Biotech, a leading biotechnology company in the development of Interleukin-15 (IL-15) targeted therapies, announces today completion of the dosing
Read more
AstraZeneca and EU Reach Settlement on COVID-19 Vaccine Delivery
AstraZeneca and the European Commission and have reached a settlement on the delivery of pending COVID-19 vaccine doses by the
Read more
UK Approves Regeneron/Roche COVID-19 Monoclonal Antibody Cocktail
The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has granted a Conditional Marketing Authorization (CMA) for Regeneron’s antibody cocktail to treat
Read more
Pfizer-BioNTech COVID-19 Vaccine First to be Fully Approved by the FDA
The U.S. Food and Drug Administration announced on Monday it has approved the Pfizer-BioNTech COVID-19 Vaccine. The vaccine which will
Read more
FDA Grants EUA for Two Next-Gen COVID-19 Assays from Thermo Fisher
The global leader in serving science, Thermo Fisher Scientific has announced that the U.S. Food and Drug Administration (FDA) has
Read more
COVID-19 antibodies enable tissue-based detection of viral infection
HistoSure’s novel monoclonal COVID-19 antibodies developed to enable tissue-based detection of viral infection in human clinical samples have shown excellent
Read more